6
Hindawi Publishing Corporation Case Reports in Hematology Volume 2012, Article ID 194797, 5 pages doi:10.1155/2012/194797 Case Report Multiple Myeloma of the Thyroid Cartilage Peter Kalina and Jeffrey B. Rykken Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA Correspondence should be addressed to Peter Kalina, [email protected] Received 15 December 2011; Accepted 28 January 2012 Academic Editor: C. Imai Copyright © 2012 P. Kalina and J. B. Rykken. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A 60-year-old male presented with hoarseness. His past medical history was remarkable for a plasmacytoma of the left maxillary sinus having been resected without systemic evidence of plasma cell myeloma (PCM), also known as multiple myeloma (MM), at the time. This maxillary sinus disease recurred and was treated with radiation. Workup for PCM was conducted. Treatment included melphalan and autologous stem cell transplant. Because of the therapeutic and prognostic implications, a Plasma cell neoplasm (PCN) in a neck mass must be carefully evaluated by clinical and pathological criteria in order to distinguish plasmacytoma from PCM. PCN involvement of the thyroid cartilage is very rare, with only 5 previously reported cases. 1. Introduction Plasma cell neoplasms (PCNs) include extramedullary plas- macytoma (EMP), solitary bone plasmacytoma (SBP), and manifestation of plasma cell myeloma (PCM). EMP and SBP are benign and local. PCM is a systemic process and the most common PCN with the worst prognosis. Workup for PCM generally includes serum electrophoresis with evaluation for the presence of a monoclonal peak, consisting of IgG with kappa light chain. This case demonstrates the possibility of an indolent course of PCM with destructive laryngeal plasmacytoma without systemic findings. PCN accounts for less than 1% of head/neck tumors. Furthermore, PCN of the thyroid cartilage is very rare. 2. Case Report A 60-year-old male presented with a three-month history of increasing hoarseness. Imaging was obtained consisting of a soft tissue neck MRI with noncontrast axial sequences (Figure 1), postcontrast coronal MRI and CT (Figure 2), postcontrast axial CT (Figure 3) and a nuclear medicine bone scan (Figure 4). His past medical history was remarkable for a plasmacytoma of the left maxillary sinus having been resected, although there was no systemic evidence of PCM at the time. This maxillary sinus disease recurred and was treated with radiation. Workup for PCM included serum electrophoresis demonstrating a monoclonal peak consisting of IgG with kappa light chain. Initial bone marrow analysis demonstrated a slight in- crease in erythroid precursors and a slight decrease in gran- ulocytic precursors. Plasma cells were borderline increased and estimated at 2-3% of the total cellularity. Immunohisto- chemical studies were essentially normal, other than a slight increase in plasma cell population identified via staining for CD138. An additional bone marrow analysis was performed nearly seven months later. At this time, the patient was five-years out from the initial plasmacytoma resection. On this second marrow evaluation, panmyeloid hyperplasia was present and a tiny aggregate of atypical plasma cells was identified and deemed worrisome for early involvement of plasma cell neoplasm. Immunophenotyping was unable to be performed as too few plasma cells were present. He initially had an early stage, indolent course of PCM with a destructive laryngeal plasmacytoma without sys- temic findings. In fact, an advanced destructive laryngeal lesion may exist with indolent PCM. Later skeletal surveys demonstrated multiple lytic lesions throughout the axial and appendicular skeleton. Treatment included high-dose melphalan and autologous stem cell transplant.

Case Report MultipleMyelomaoftheThyroidCartilage · Case Report MultipleMyelomaoftheThyroidCartilage ... Recent neck lump detected by patient with increasing hoarseness and progressive

  • Upload
    doxuyen

  • View
    221

  • Download
    0

Embed Size (px)

Citation preview

Hindawi Publishing CorporationCase Reports in HematologyVolume 2012, Article ID 194797, 5 pagesdoi:10.1155/2012/194797

Case Report

Multiple Myeloma of the Thyroid Cartilage

Peter Kalina and Jeffrey B. Rykken

Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA

Correspondence should be addressed to Peter Kalina, [email protected]

Received 15 December 2011; Accepted 28 January 2012

Academic Editor: C. Imai

Copyright © 2012 P. Kalina and J. B. Rykken. This is an open access article distributed under the Creative Commons AttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.

A 60-year-old male presented with hoarseness. His past medical history was remarkable for a plasmacytoma of the left maxillarysinus having been resected without systemic evidence of plasma cell myeloma (PCM), also known as multiple myeloma (MM),at the time. This maxillary sinus disease recurred and was treated with radiation. Workup for PCM was conducted. Treatmentincluded melphalan and autologous stem cell transplant. Because of the therapeutic and prognostic implications, a Plasmacell neoplasm (PCN) in a neck mass must be carefully evaluated by clinical and pathological criteria in order to distinguishplasmacytoma from PCM. PCN involvement of the thyroid cartilage is very rare, with only 5 previously reported cases.

1. Introduction

Plasma cell neoplasms (PCNs) include extramedullary plas-macytoma (EMP), solitary bone plasmacytoma (SBP), andmanifestation of plasma cell myeloma (PCM). EMP and SBPare benign and local. PCM is a systemic process and the mostcommon PCN with the worst prognosis. Workup for PCMgenerally includes serum electrophoresis with evaluation forthe presence of a monoclonal peak, consisting of IgG withkappa light chain. This case demonstrates the possibilityof an indolent course of PCM with destructive laryngealplasmacytoma without systemic findings. PCN accounts forless than 1% of head/neck tumors. Furthermore, PCN of thethyroid cartilage is very rare.

2. Case Report

A 60-year-old male presented with a three-month historyof increasing hoarseness. Imaging was obtained consistingof a soft tissue neck MRI with noncontrast axial sequences(Figure 1), postcontrast coronal MRI and CT (Figure 2),postcontrast axial CT (Figure 3) and a nuclear medicine bonescan (Figure 4). His past medical history was remarkablefor a plasmacytoma of the left maxillary sinus having beenresected, although there was no systemic evidence of PCMat the time. This maxillary sinus disease recurred and was

treated with radiation. Workup for PCM included serumelectrophoresis demonstrating a monoclonal peak consistingof IgG with kappa light chain.

Initial bone marrow analysis demonstrated a slight in-crease in erythroid precursors and a slight decrease in gran-ulocytic precursors. Plasma cells were borderline increasedand estimated at 2-3% of the total cellularity. Immunohisto-chemical studies were essentially normal, other than a slightincrease in plasma cell population identified via staining forCD138.

An additional bone marrow analysis was performednearly seven months later. At this time, the patient wasfive-years out from the initial plasmacytoma resection. Onthis second marrow evaluation, panmyeloid hyperplasia waspresent and a tiny aggregate of atypical plasma cells wasidentified and deemed worrisome for early involvement ofplasma cell neoplasm. Immunophenotyping was unable tobe performed as too few plasma cells were present.

He initially had an early stage, indolent course of PCMwith a destructive laryngeal plasmacytoma without sys-temic findings. In fact, an advanced destructive laryngeallesion may exist with indolent PCM. Later skeletal surveysdemonstrated multiple lytic lesions throughout the axialand appendicular skeleton. Treatment included high-dosemelphalan and autologous stem cell transplant.

2 Case Reports in Hematology

(a) (b)

Figure 1: Axial T1 (a) and T2 (b), noncontrast: homogeneous, well-defined mass of the right thyroid cartilage laminae.

(a) (b)

Figure 2: Coronal MRI (a) and coronal CT (b); postcontrast homogeneous enhancement of the mass.

3. Discussion

Plasma cell neoplasms (PCN) represent a monoclonal plas-ma cell proliferation. The three types, extramedullary plas-macytoma (EMP), solitary bone plasmacytoma (SBP), andmanifestation of PCM (or multiple myeloma), representdistinct manifestations of the same disease, representing adisease continuum [1]. EMP (3% of PCN) is a local plasmacell tumor outside of marrow. Of these, 50–60% progress

to PCM [2]. The larynx is involved in 5–20% cases butrarely involves the cartilage. SBP represents a local marrowplasma cell proliferation manifesting as an intraosseous lyticlesion. Of these, 20–30% progress to PCM [2]. EMP and SBPare benign and local, without systemic disease or criteria ofMM based on negative electrophoresis, bone marrow biopsy,and radiographs. PCM is the most common PCN. It is asystemic disease with disseminated involvement and thus hasthe worst prognosis. Findings include bone pain, anemia,

Case Reports in Hematology 3

Ta

ble

1:C

ompa

riso

nof

publ

ish

edre

port

sof

plas

ma

cell

mye

lom

a(o

rm

ult

iple

mye

lom

a)w

ith

thyr

oid

cart

ilage

invo

lvem

ent.

Au

thor

sD

emog

raph

ics

Init

iald

iagn

osis

ofm

ult

iple

mye

lom

aP

rese

nta

tion

ofth

yroi

dca

rtila

gele

sion

Imag

ing

Skel

etal

surv

eyat

tim

eof

pres

enti

ng

thyr

oid

lesi

on

Trea

tmen

tof

thyr

oid

lesi

on

Van

Dyk

eC

etal

.[3]

62-y

ear-

old

mal

eE

xpan

sile

lyti

cri

ble

sion

Wor

sen

ing

hoa

rsen

ess

for

6m

onth

san

dn

eck

swel

ling

for

wee

ksC

ontr

ast-

enh

ance

dC

TM

ult

iple

bony

lesi

ons

onra

diog

raph

icsu

rvey

Rad

iati

onth

erap

y

Saad

Ret

al.[

4]79

-yea

r-ol

dm

ale

Ost

eoly

tic

lesi

onof

6th

thor

acic

vert

ebra

Nec

km

ass

asso

ciat

edw

ith

pain

upo

nsw

allo

win

gC

ontr

ast-

enh

ance

dC

TM

ult

iple

lyti

cbo

nyle

sion

son

radi

ogra

phic

surv

eyN

otre

por

ted

Gro

ssM

etal

.[5

]50

-yea

r-ol

dm

ale

Nec

km

ass

Pro

gres

sive

lyen

larg

ing

nec

km

ass

for

6m

onth

sw

ith

resp

irat

ory

dist

ress

and

stri

dor

Non

-con

tras

tC

TM

ult

iple

lyti

cbo

nyle

sion

son

radi

ogra

phic

surv

ey

Rad

iati

onan

dch

emot

her

apy

(vin

cris

tin

e,do

xoru

bici

n,a

nd

dexa

met

has

one;

late

rch

ange

dto

mel

phal

an)

Asl

anI

etal

.[1]

70-y

ear-

old

mal

eN

eck

mas

sSl

igh

th

oars

enes

san

dn

eck

fulln

ess

for

4m

onth

sN

on-c

ontr

ast

CT

No

lesi

ons

dem

onst

rate

d

Deb

ulk

ing

ofm

ass

and

radi

atio

nth

erap

y

Sosn

aJ

etal

.[6]

54-y

ear-

old

mal

eN

eck

mas

s

Rec

ent

nec

klu

mp

dete

cted

bypa

tien

tw

ith

incr

easi

ng

hoa

rsen

ess

and

prog

ress

ive

dysp

nea

Non

-con

tras

tC

TM

ult

iple

lyti

cbo

ne

lesi

ons

onra

diog

raph

icsu

rvey

Rad

iati

onan

dch

emot

her

apy

(vin

cris

tin

e,do

xoru

bici

n,a

nd

dexa

met

has

one;

late

rgi

ven

mel

phal

an)

Shim

ada

Tet

al.

[2]

72-y

ear-

old

mal

ePa

thol

ogic

cerv

ical

vert

ebra

lbod

yfr

actu

re

Asy

mpt

omat

ic,i

nci

den

tally

disc

over

edon

CT

ofce

rvic

alsp

ine

Non

-con

tras

tC

TN

oad

diti

onal

lesi

ons

onw

hol

ebo

dysc

inti

grap

hy

Che

mot

hera

pyan

d/or

bon

em

arro

wtr

ansp

lan

tfe

ltin

dica

ted,

but

no

ther

apy

give

n,d

ue

topa

tien

t’sag

ean

dde

men

tia.

Kal

ina

Pet

al.

[7]

60-y

ear-

old

mal

e

Nas

olac

rim

aldu

ctob

stru

ctio

nw

ith

epip

hor

iadu

eto

para

nas

alsi

nu

sm

ass

Hoa

rsen

ess

for

3m

onth

s

Con

tras

t-en

han

ced

MR

I;co

ntr

ast-

enh

ance

dC

T,an

dbo

ne

scan

Two

lyti

cle

sion

s,on

eea

chof

the

sku

llan

dle

fthu

mer

us

Au

tolo

gou

sbo

ne

mar

row

tran

spla

nt

4 Case Reports in Hematology

(a) (b)

Figure 3: CT, postcontrast, soft tissue (a) and bone windows (b) Uniformly expanded right thyroid cartilage laminae.

Figure 4: Nuclear Medicine Bone Scan: Confirms increased uptakeof the lesion.

renal failure, marrow plasmacytomas, lytic bone lesions, anda monoclonal gamma globulin peak. Patients may also haveclinically silent disseminated extraosseous disease.

PCN accounts for less than 1% of head/neck tumors [6].EMP is usually a submucosal soft tissue mass in a paranasalsinus, nasal cavity, or nasopharynx. Most PCNs of the larynxrepresent EMP without PCM rather than extraosseous PCM.The most common symptom of laryngeal plasmacytoma isslowly progressive hoarseness. PCN of the thyroid cartilage isvery rare.

There are two theories to explain cartilage involvement[3]: direct cartilage invasion by adjacent plasmacytoma ormetaplasia of cartilage to bone with formation of a marrowcavity in which a plasmacytoma originates. It is considered

an extraosseous manifestation of PCM when cartilage isinvolved because it occurs in ossified cartilage rather thanbone. It is rare compared with intramedullary PCM. Lesionsare typically homogeneous, well defined, and enhancing.Uniformly expanded thyroid cartilage laminae and no softtissue mass suggest that a plasmacytoma originates in thethyroid ala rather than being eroded by adjacent soft tissueplasmacytoma.

The three PCN variants are histologically indistinguish-able. Because of the therapeutic and prognostic implications,a PCN in a neck mass must be carefully evaluated by clinicaland pathological criteria in order to distinguish plasmacy-toma from PCM.

Treatment of PCN of the larynx is local or wide excisionas well as radiation (EMP/SBP are radiosensitive). Treatmentof PCM includes melphalan/prednisolone, radiation forlocal control, and autologous bone marrow transplant withperipheral blood stem cells.

PCN involvement of the thyroid cartilage is very rare,with only 6 previously reported cases (Table 1) [1–6]. In 3 ofthese cases, the neck mass was the initial presenting featureof PCN. In 4 of 7 cases, including this case, hoarseness was apresenting feature of the thyroid cartilage lesion.

References

[1] I. Aslan, H. Yenice, and N. Baserer, “An indolent courseof multiple myeloma mimicking a solitary thyroid cartilageplasmacytoma,” European Archives of Oto-Rhino-Laryngology,vol. 259, no. 2, pp. 84–86, 2002.

[2] T. Shimada, M. Matsui, K. Ikebuchi et al., “Multiple myelomainvolving the thyroid cartilage,” Auris Nasus Larynx, vol. 34, no.2, pp. 277–279, 2007.

[3] C. W. Van Dyke, T. J. Masaryk, and P. Lavertu, “Multiplemyeloma involving the thyroid cartilage,” American Journal ofNeuroradiology, vol. 17, no. 3, pp. 570–572, 1996.

[4] R. Saad, S. Raab, Y. Liu, P. Pollice, and J. F. Silverman, “Plas-macytoma of the larynx diagnosed by fine-needle aspiration

Case Reports in Hematology 5

cytology: a case report,” Diagnostic Cytopathology, vol. 24, no.6, pp. 408–411, 2001.

[5] M. Gross, R. Eliashar, P. Petrova, A. Goldfarb, and J. Y. Sichel,“Neck mass as primary manifestation of multiple myelomaoriginating in the thyroid cartilage,” Otolaryngology—Head andNeck Surgery, vol. 126, no. 3, pp. 326–328, 2002.

[6] J. Sosna, B. S. Slasky, O. Paltiel, G. Pizov, and E. Libson,“Multiple myeloma involving the thyroid cartilage: case report,”American Journal of Neuroradiology, vol. 23, no. 2, pp. 316–318,2002.

[7] P. Kalina and J. Rykken, “Multiple myeloma of the thyroidcartilage,” Case Reports in Hematology, vol. 2012, no. 11, pp. 1–5, 2012.

Submit your manuscripts athttp://www.hindawi.com

Stem CellsInternational

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

MEDIATORSINFLAMMATION

of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Behavioural Neurology

EndocrinologyInternational Journal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Disease Markers

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

BioMed Research International

OncologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Oxidative Medicine and Cellular Longevity

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

PPAR Research

The Scientific World JournalHindawi Publishing Corporation http://www.hindawi.com Volume 2014

Immunology ResearchHindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Journal of

ObesityJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Computational and Mathematical Methods in Medicine

OphthalmologyJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Diabetes ResearchJournal of

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Research and TreatmentAIDS

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Gastroenterology Research and Practice

Hindawi Publishing Corporationhttp://www.hindawi.com Volume 2014

Parkinson’s Disease

Evidence-Based Complementary and Alternative Medicine

Volume 2014Hindawi Publishing Corporationhttp://www.hindawi.com